PMDA drug package insert
リンラキサー錠125mg
PMDA Prescription drug · 大正製薬株式会社 · package insert Aug 28, 2025
Key facts
| Brand names | リンラキサー錠125mg, リンラキサー錠250mg |
|---|---|
| Nonproprietary names | クロルフェネシンカルバミン酸エステル |
| Companies | 製造販売／大正製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 筋緊張性疼痛疾患治療剤 |
| Therapeutic category codes | 871225 |
| YJ codes | 1225001F1114, 1225001F2250 |
| Approval numbers | 21800AMX10185000, 21800AMX10186000 |
| Package insert edition | 第1版 |
| Package insert date | Aug 28, 2025 |
| PMDA document key | 400059_1225001F1114_1 |
| PMDA company code | 400059 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: